ArticleBMC medical informatics and decision making2026
An intelligent lung cancer detection from computed tomography images using robust optimal deep transfer learning with XAI model.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer remains as one such leading cause of cancer related mortality around the world, demanding precise and early detection through intelligent and effective diagnostic systems. This model presents a Modified Shark Smell Optimization (MSSO) aided Deep Transfer Learning framework for explainable lung cancer detection using Computed Tomography (CT) images. The workflow begins with preprocessing input image carried by segmentation using DeepLabV3 + model to, precisely isolate lung regions and thus eradicate background noise. The features segmented are further processed using Enriched DNN model for enhancing the robustness of feature and to reduce redundancy. Subsequently, the MSSO approach is employed for attaining most relevant and discriminative feature subset for classification. An optimized feature subset s then classified with the use of Deep Transfer Learning-based Inception ResNetV2 model, which enhances recognition accuracy and ensures fast convergence. For enhancing transparency of model and clinical trust, Explainable AI (XAI) is incorporated using GradCAM + + for visualizing critical lung regions thus contributing to decision making process. An experimental outcome on LIDC-IDRI dataset demonstrates that proposed hybrid MSSO-InceptionResNetV2 scheme attains superior accuracy, sensitivity, specificity, ROC, and precision with reduced FPR and computational time on comparing traditional models considered. Hence, the proposed scheme offers reliable and interpretable solutions for automated diagnosis of lung cancer, offering significant potential for clinical integration, early intervention, and enhanced patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.